These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 822264)

  • 1. Towards a diagnosis of "health-care" disease.
    Wright JT
    Med J Aust; 1976 May; 1(20):752-3. PubMed ID: 822264
    [No Abstract]   [Full Text] [Related]  

  • 2. The medical profession and the pharmaceutical industry: when will we open our eyes?
    Woodruff TG
    Med J Aust; 2004 Oct; 181(8):458. PubMed ID: 15487968
    [No Abstract]   [Full Text] [Related]  

  • 3. Consumers' preferences for the communication of risk information in drug advertising.
    Davis JJ
    Health Aff (Millwood); 2007; 26(3):863-70. PubMed ID: 17485767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. When ads trump evidence: is direct-to-consumer advertising leading practice?
    Nelson R
    Am J Nurs; 2007 Oct; 107(10):25-6. PubMed ID: 17895720
    [No Abstract]   [Full Text] [Related]  

  • 5. [About medicines. Production, advertising, abuse and side effects of our drugs].
    Spegg H
    Dtsch Krankenpflegez; 1974 Jun; 27(6):290-7. PubMed ID: 4495221
    [No Abstract]   [Full Text] [Related]  

  • 6. Are old drugs better than new?
    Gupta S
    Time; 2002 May; 159(19):89. PubMed ID: 12026510
    [No Abstract]   [Full Text] [Related]  

  • 7. [Round table discussion. Therapy injury (author's transl)].
    Verh Dtsch Ges Pathol; 1972; 56():320-31. PubMed ID: 4130834
    [No Abstract]   [Full Text] [Related]  

  • 8. Direct-to-consumer advertising under the radar: the need for realistic drugs policy in Australia.
    Mackenzie FJ; Jordens CF; Ankeny RA; McPhee J; Kerridge IH
    Intern Med J; 2007 Apr; 37(4):224-8. PubMed ID: 17388861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Information on drugs and drug hazards--a task of professional policy].
    Kimbel KH
    Med Klin; 1975 Oct; 70(44):1790-2. PubMed ID: 1186584
    [No Abstract]   [Full Text] [Related]  

  • 10. [Prevention of avoidable iatrogenic disease: when patient safety joins with health care economics].
    Queneau P; Bergmann JF
    Therapie; 2001; 56(2):163-8. PubMed ID: 11471369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bold suggestion by Smith.
    Cohen D
    PLoS Med; 2005 Jul; 2(7):e226. PubMed ID: 16033320
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical diagnosis in patients with complications of current drug therapy].
    Kondurtsev VA
    Ter Arkh; 1982; 54(9):103-8. PubMed ID: 7179134
    [No Abstract]   [Full Text] [Related]  

  • 13. The fight against disease mongering: generating knowledge for action.
    Moynihan R; Henry D
    PLoS Med; 2006 Apr; 3(4):e191. PubMed ID: 16597180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Update and evaluation of Australian guidelines. Industry perspective.
    Carmine B
    Med Care; 1996 Dec; 34(12 Suppl):DS226-32. PubMed ID: 8969330
    [No Abstract]   [Full Text] [Related]  

  • 15. Forecasting the future.
    Tecnologica; 1999 Dec; ():1, 3-6, 14-5. PubMed ID: 10848110
    [No Abstract]   [Full Text] [Related]  

  • 16. Drug advertising.
    Bell KD
    Med J Aust; 1987 Oct; 147(7):361. PubMed ID: 3657662
    [No Abstract]   [Full Text] [Related]  

  • 17. [Public health. The nurse and the avoidable medication risk].
    Queneau P
    Soins; 1999 Jun; (636):50-1. PubMed ID: 10595239
    [No Abstract]   [Full Text] [Related]  

  • 18. Drug promotion and patient safety.
    Elmes PC
    Adv Sci; 1967 Feb; 23(116):517-20. PubMed ID: 6044858
    [No Abstract]   [Full Text] [Related]  

  • 19. Drug advertising.
    Moulds RF; Wing LM
    Med J Aust; 1989 Apr; 150(7):410-1. PubMed ID: 2716670
    [No Abstract]   [Full Text] [Related]  

  • 20. Drugs in 2001: a number of ruses unveiled.
    Prescrire Int; 2002 Apr; 11(58):58-60. PubMed ID: 11987319
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.